Senior Director, New Ventures and Transactions lead for Neuroscience, at Johnson & Johnson Innovation
Lilian is Senior Director, New Ventures and Transactions lead for Neuroscience, at Johnson & Johnson Innovation. He has experience in transacting across a range of collaboration and licensing opportunities, form small molecules and antibodies, technologies, multiparty consortium agreements to digital health.
Lilian has over 20 years’ experience in Drug Discovery gained through working in both large pharma (AstraZeneca) and CRO (Galapagos/Charles River) environments.
Lilian received his postgraduate degree in Molecular and Supramolecular Organic Chemistry and his Ph.D. in Organic Chemistry from Louis Pasteur University. He was a Post-Doctoral Fellow at the University of York. Over the years, he has been involved in the successful delivery of nine clinical candidates, some of which are still in clinical evaluation. Lilian is the author and co-author of 78 publications and patents, and of a book on Medicinal Chemistry.
(+44) 1223 496 000
Babraham Bioscience Technologies Ltd
Babraham Research Campus
CB22 3AT, United Kingdom
01223 813 557